Corporate
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
L'Ecole du recrutement L'Ecole du recrutement
hrtech, Staffing and Recruiting
Not capitalistic
Not partnership
Event

11 Dec 2015


RSM France RSM France
fintech, Accounting
Other

26 May 2015


Guerbet Guerbet
Pharmaceutical Manufacturing
Other

18 Oct 2017


Zenika Zenika
it services, transporttech, IT Services and IT Consulting
Not capitalistic
Not partnership
Event

2 Mar 2020


NCDC NCDC
it services, IT Services and IT Consulting
Not capitalistic
Partnership
Event

15 Feb 2020


ADERLY / Invest in Lyon Agency ADERLY / Invest in Lyon Agency
International Trade and Development
Other

3 May 2018

29 Oct 2023



MaaT Pharma MaaT Pharma
biotech, deeptech, Biotechnology Research
Not capitalistic
Not partnership
Event

12 May 2016


ENE - Experts du Numérique en Entreprises ENE - Experts du Numérique en Entreprises
e-commerce, Software Development
Other

6 Feb 2013


Kenya Medical Research Institute (KEMRI) Kenya Medical Research Institute (KEMRI)
Research Services
Other

3 Jul 2020


SPRING LAB SPRING LAB
consulting, Business Consulting and Services
Other

2 Jul 2020

9 Mar 2023



Radars
Loading...